Endpoints News 生物医药· ENDPOINTS·· 2026-09-30AI 评分9
AbbVie 湿疹药物展现 II 期疗效;BioMarin 裁员 117 人
AbbVie's eczema drug shows benefit in Phase 2; BioMarin lays off 117
AI 导读
AbbVie 公布其治疗湿疹药物的 II 期数据,显示临床获益。BioMarin 宣布裁员 117 人。Sarepta、Rafael Holdings、Sagimet 等多家生物医药公司亦有相关动态。
正文
Plus news about Sarepta, Rafael Holdings, Sagimet, Pyxis Oncology, Connect Biopharma, Asahi Kasei, Astrocyte Pharmaceuticals, GSK, Wave and Kailera.
AbbVie unveils Phase 2 data for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news